Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

5-tungsto-2-antimoniate

Known as: 21-Tungsto-9-antimonate, 5-Tungsto-2-antimonate, Antimoniotungstate 
A non-nucleoside reverse transcriptase inhibitor. Antimoniotungstate is a mineral condensed ion with a cryptic structure.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
SummaryThe effects of up to 12 daily doses of HPA-23 (ammonium 5-tungsto-2-antimoniate) on scrapie were studied using five… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
1990
1990
The anti-viral drug HPA-23 (ammonium 21-tungsto-9-antimonate) has been proposed for use in the combat against AIDS. The two… Expand
Review
1987
Review
1987
The AIDS Surveillance System in Japan was set up in 1984 and by 1987, 29 AIDS patients had been reported. 10 were homosexuals… Expand
Review
1986
Review
1986
The current epidemic of acquired immunodeficiency syndrome (AIDS) poses a major threat to our population. Urgently needed are… Expand
Highly Cited
1985
Highly Cited
1985
The antiviral activity of HPA 23 was assessed by viral isolation studies in the lymphocytes of 4 patients with acquired… Expand
Review
1985
Review
1985
Human T-lymphotropic virus type III is susceptible to attack at various sites during its replicative cycle. Inhibitors of reverse… Expand
1983
1983
The 21-tungsto-9-antimonate (TA, HPA 23), a polyoxotungstate, has shown a significant antiviral activity in vivo and in vitro. It… Expand
1977
1977
Abstract We examined the effects of the heteropolyanion 5 -tungsto- 2 -antimoniate on Herpes virus saimiri , Epstein-Barr virus… Expand
1976
1976
Ammonium 5-tungsto-2-antimoniate (HPA 23) protected micr partially or completely against two strains of encephalomyocarditis (EMC… Expand
  • table 2
  • table 3
Highly Cited
1974
Highly Cited
1974